Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 21% ± 4% | |
endothelial cell of lymphatic vessel | 4 studies | 25% ± 9% | |
smooth muscle cell | 4 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of FLNC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 76% | 32279.50 | 187 / 245 | 98% | 85.00 | 490 / 502 |
intestine | 71% | 54997.50 | 682 / 966 | 69% | 18.77 | 363 / 527 |
esophagus | 65% | 41963.29 | 944 / 1445 | 69% | 24.49 | 126 / 183 |
bladder | 81% | 70818.81 | 17 / 21 | 48% | 16.25 | 240 / 504 |
uterus | 81% | 27212.28 | 138 / 170 | 46% | 37.49 | 211 / 459 |
stomach | 43% | 24528.97 | 153 / 359 | 68% | 46.52 | 194 / 286 |
muscle | 100% | 334732.94 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 137408.15 | 825 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 32544.76 | 1249 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 174.11 | 36 / 2642 | 78% | 35.12 | 547 / 705 |
pancreas | 0% | 0 | 0 / 328 | 76% | 22.06 | 136 / 178 |
lung | 15% | 2486.85 | 84 / 578 | 45% | 24.12 | 518 / 1155 |
ovary | 8% | 1308.86 | 14 / 180 | 48% | 10.85 | 207 / 430 |
eye | 0% | 0 | 0 / 0 | 53% | 9.50 | 42 / 80 |
skin | 26% | 5971.81 | 475 / 1809 | 22% | 7.92 | 106 / 472 |
kidney | 1% | 112.08 | 1 / 89 | 44% | 10.92 | 399 / 901 |
breast | 3% | 513.40 | 16 / 459 | 37% | 4.07 | 418 / 1118 |
liver | 0% | 38.12 | 1 / 226 | 22% | 7.56 | 90 / 406 |
tonsil | 0% | 0 | 0 / 0 | 20% | 7.56 | 9 / 45 |
adipose | 15% | 2679.88 | 186 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 76.78 | 1 / 258 | 11% | 1.97 | 26 / 230 |
thymus | 3% | 483.59 | 17 / 653 | 9% | 0.99 | 54 / 605 |
peripheral blood | 1% | 147.25 | 8 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045214 | Biological process | sarcomere organization |
GO_0042383 | Cellular component | sarcolemma |
GO_0005856 | Cellular component | cytoskeleton |
GO_0016528 | Cellular component | sarcoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030018 | Cellular component | Z disc |
GO_0005886 | Cellular component | plasma membrane |
GO_0043034 | Cellular component | costamere |
GO_0005737 | Cellular component | cytoplasm |
GO_0045171 | Cellular component | intercellular bridge |
GO_0005925 | Cellular component | focal adhesion |
GO_0030506 | Molecular function | ankyrin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FLNC |
Protein name | Filamin C Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) |
Synonyms | ABPL FLN2 |
Description | FUNCTION: Muscle-specific filamin, which plays a central role in sarcomere assembly and organization . Critical for normal myogenesis, it probably functions as a large actin-cross-linking protein with structural functions at the Z lines in muscle cells. May be involved in reorganizing the actin cytoskeleton in response to signaling events (By similarity). . |
Accessions | Q14315 ENST00000346177.6 [Q14315-2] ENST00000325888.13 [Q14315-1] B5AGT3 |